From MarketBeat:



Alphatec Holdings Inc. executive vice president, David Sponsel, sold 2,500 shares of company stock worth $37,500. After the sale, he directly owns 557,780 shares valued at $8,366,700. Alphatec stock traded at $15.34, with a 52-week low of $8.66 and high of $19.14. It has a market cap of $2.09 billion. The company last announced $0.35 EPS. A number of large investors have recently bought and sold shares of the company. Analysts have recently cut price targets on the company’s stock, giving it a “Moderate Buy” rating and a consensus price target of $22.14.

Alphatec is a medical technology company that designs, develops, and advances technologies for the surgical treatment of spinal disorders. It manufactures and sells implants and instruments through third-party suppliers. The company last announced $0.35 EPS and a consensus price target of $22.14.

Additionally, there’s an ongoing debate regarding the five best stocks recommended by top analysts, of which Alphatec is not included in the list. Investors are keen on buying and selling 13 stocks quickly, which includes Alphatec stock.



Read more: Alphatec Holdings, Inc. (NASDAQ:ATEC) EVP Sells $37,500.00 in Stock